EcoDrugPlus

Potassium Voltage-Gated Channel Subfamily D Member 3

Ensembl ID : ENSCMIG00000014453
Gene Symbol: KCND3
3 Cross references
267 Possible Orthologues:

Potassium Voltage-Gated Channel Subfamily Q Member 2

Ensembl ID : ENSCMIG00000001897
Gene Symbol: KCNQ2
3 Cross references
250 Possible Orthologues:

Potassium Voltage-Gated Channel Subfamily Q Member 3

Ensembl ID : ENSCMIG00000015345
Gene Symbol: KCNQ3
3 Cross references
193 Possible Orthologues:

Presenilin 1

Ensembl ID : ENSCMIG00000018415
Gene Symbol: PSEN1
4 Cross references
201 Possible Orthologues:

Presenilin 2

Ensembl ID : ENSCMIG00000003247
Gene Symbol: PSEN2
4 Cross references
206 Possible Orthologues:

Presenilin-1-Like

Ensembl ID : ENSCMIG00000010871
Gene Symbol: LOC103191072
3 Cross references
201 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSCMIG00000012168
Gene Symbol: PGR
3 Cross references
194 Possible Orthologues:

Prostacyclin Receptor-Like

Ensembl ID : ENSCMIG00000011179
Gene Symbol: LOC103175255
4 Cross references
244 Possible Orthologues:

Prostaglandin D2 Receptor

Ensembl ID : ENSCMIG00000011180
Gene Symbol: PTGDR
4 Cross references
118 Possible Orthologues:

Prostaglandin E Receptor 1

Ensembl ID : ENSCMIG00000017208
Gene Symbol: PTGER1
3 Cross references
306 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSCMIG00000001176
Gene Symbol: PTGER3
1 Cross references
197 Possible Orthologues:

Prostaglandin F Receptor

Ensembl ID : ENSCMIG00000009413
Gene Symbol: PTGFR
4 Cross references
195 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).